X-107841155-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_012216.4(MID2):c.490C>T(p.Arg164Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,209,243 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.0000091 ( 0 hom. 4 hem. )
Consequence
MID2
NM_012216.4 missense
NM_012216.4 missense
Scores
5
10
2
Clinical Significance
Conservation
PhyloP100: 0.753
Genes affected
MID2 (HGNC:7096): (midline 2) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to microtubular structures in the cytoplasm. Alternate splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MID2 | NM_012216.4 | c.490C>T | p.Arg164Cys | missense_variant | 2/10 | ENST00000262843.11 | NP_036348.2 | |
MID2 | NM_001382751.1 | c.430C>T | p.Arg144Cys | missense_variant | 2/10 | NP_001369680.1 | ||
MID2 | NM_052817.3 | c.490C>T | p.Arg164Cys | missense_variant | 2/10 | NP_438112.2 | ||
MID2 | NM_001382752.1 | c.430C>T | p.Arg144Cys | missense_variant | 2/10 | NP_001369681.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MID2 | ENST00000262843.11 | c.490C>T | p.Arg164Cys | missense_variant | 2/10 | 1 | NM_012216.4 | ENSP00000262843 | ||
MID2 | ENST00000443968.2 | c.490C>T | p.Arg164Cys | missense_variant | 2/10 | 1 | ENSP00000413976 | P1 | ||
MID2 | ENST00000451923.1 | c.430C>T | p.Arg144Cys | missense_variant | 2/2 | 3 | ENSP00000410730 |
Frequencies
GnomAD3 genomes AF: 0.0000270 AC: 3AN: 111302Hom.: 0 Cov.: 23 AF XY: 0.0000299 AC XY: 1AN XY: 33486
GnomAD3 genomes
AF:
AC:
3
AN:
111302
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33486
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000548 AC: 1AN: 182551Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67117
GnomAD3 exomes
AF:
AC:
1
AN:
182551
Hom.:
AF XY:
AC XY:
0
AN XY:
67117
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1097941Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 4AN XY: 363303
GnomAD4 exome
AF:
AC:
10
AN:
1097941
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
363303
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000270 AC: 3AN: 111302Hom.: 0 Cov.: 23 AF XY: 0.0000299 AC XY: 1AN XY: 33486
GnomAD4 genome
AF:
AC:
3
AN:
111302
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.490C>T (p.R164C) alteration is located in exon 2 (coding exon 2) of the MID2 gene. This alteration results from a C to T substitution at nucleotide position 490, causing the arginine (R) at amino acid position 164 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;M
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
1.0, 1.0
.;D;D
Vest4
0.49, 0.51
MutPred
0.46
.;Loss of catalytic residue at R164 (P = 0.018);Loss of catalytic residue at R164 (P = 0.018);
MVP
MPC
1.5
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at